{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T17:18:36Z","timestamp":1795281516641,"version":"4.10.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/OFYIRG24jul-0034"],"award-info":[{"award-number":["NMRC\/OFYIRG24jul-0034"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["C243512007"],"award-info":[{"award-number":["C243512007"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75027-3","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:58:00Z","timestamp":1782788280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-6134","authenticated-orcid":false,"given":"Shi Yong","family":"Neo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-4525","authenticated-orcid":false,"given":"Yu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyue Yuan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka P.","family":"Rajapakse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9305-7652","authenticated-orcid":false,"given":"Timothy Wai Ho","family":"Shuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-8255","authenticated-orcid":false,"given":"Le","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem","family":"Kajiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Shi","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Wei","family":"Neo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4623-4633","authenticated-orcid":false,"given":"Li Yen","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-9075","authenticated-orcid":false,"given":"Xinsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-8527","authenticated-orcid":false,"given":"Hartman","family":"Johan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4794-1564","authenticated-orcid":false,"given":"Shanshan Wu","family":"Howland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-7153","authenticated-orcid":false,"given":"Joe Poh Sheng","family":"Yeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra Kumar","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4660-3187","authenticated-orcid":false,"given":"Elaine","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-3685","authenticated-orcid":false,"given":"Hanry","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-3453","authenticated-orcid":false,"given":"Han Chong","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-469X","authenticated-orcid":false,"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong-Peng","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"75027_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","volume":"20","author":"ND Huntington","year":"2020","unstructured":"Huntington, N. D., Cursons, J. & Rautela, J. The cancer-natural killer cell immunity cycle. Nat. Rev. Cancer 20, 437\u2013454 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"75027_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503\u2013510 (2008).","journal-title":"Nat. Immunol."},{"key":"75027_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu, E. et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N. Engl. J. Med. 382, 545\u2013553 (2020).","journal-title":"N. Engl. J. Med."},{"key":"75027_CR4","doi-asserted-by":"publisher","unstructured":"Neo, S. Y., Xu, S., Chong, J., Lam, K. P. & Wu, J. Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2022-006434 (2023).","DOI":"10.1136\/jitc-2022-006434"},{"key":"75027_CR5","doi-asserted-by":"publisher","unstructured":"Chretien, S., Zerdes, I., Bergh, J., Matikas, A. & Foukakis, T. Beyond PD-1\/PD-L1 inhibition: what the future holds for breast cancer immunotherapy. Cancers https:\/\/doi.org\/10.3390\/cancers11050628 (2019).","DOI":"10.3390\/cancers11050628"},{"key":"75027_CR6","doi-asserted-by":"publisher","unstructured":"Chen, Z., Yang, Y., Liu, L. L. & Lundqvist, A. Strategies to augment natural killer (NK) cell activity against solid tumors. Cancers https:\/\/doi.org\/10.3390\/cancers11071040 (2019).","DOI":"10.3390\/cancers11071040"},{"key":"75027_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/cmi.2015.96","volume":"13","author":"H Peng","year":"2016","unstructured":"Peng, H., Wisse, E. & Tian, Z. Liver natural killer cells: subsets and roles in liver immunity. Cell Mol. Immunol. 13, 328\u2013336 (2016).","journal-title":"Cell Mol. Immunol."},{"key":"75027_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.22034","volume":"47","author":"B Gao","year":"2008","unstructured":"Gao, B., Jeong, W. I. & Tian, Z. Liver: an organ with predominant innate immunity. Hepatology 47, 729\u2013736 (2008).","journal-title":"Hepatology"},{"key":"75027_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nri1088","volume":"3","author":"F Colucci","year":"2003","unstructured":"Colucci, F., Caligiuri, M. A. & Di Santo, J. P. What does it take to make a natural killer? Nat. Rev. Immunol. 3, 413\u2013425 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"75027_CR10","doi-asserted-by":"publisher","first-page":"108284","DOI":"10.1016\/j.celrep.2020.108284","volume":"33","author":"L He","year":"2020","unstructured":"He, L. et al. A regulation loop between YAP and NR4A1 balances cell proliferation and apoptosis. Cell Rep. 33, 108284 (2020).","journal-title":"Cell Rep."},{"key":"75027_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14420","volume":"8","author":"XL Bian","year":"2017","unstructured":"Bian, X. L. et al. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation. Nat. Commun. 8, 14420 (2017).","journal-title":"Nat. Commun."},{"key":"75027_CR12","doi-asserted-by":"publisher","first-page":"27412","DOI":"10.1073\/pnas.2002997117","volume":"117","author":"PB Yang","year":"2020","unstructured":"Yang, P. B. et al. Blocking PPARgamma interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. Proc. Natl. Acad. Sci. USA. 117, 27412\u201327422 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75027_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41420-024-02019-x","volume":"10","author":"H Shi","year":"2024","unstructured":"Shi, H. et al. Nur77-IRF1 axis inhibits esophageal squamous cell carcinoma growth and improves anti-PD-1 treatment efficacy. Cell Death Discov. 10, 254 (2024).","journal-title":"Cell Death Discov."},{"key":"75027_CR14","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.4049\/jimmunol.1801565","volume":"202","author":"C Tan","year":"2019","unstructured":"Tan, C. et al. Nur77 links chronic antigen stimulation to B cell tolerance by restricting the survival of self-reactive B cells in the periphery. J. Immunol. 202, 2907\u20132923 (2019).","journal-title":"J. Immunol."},{"key":"75027_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.4049\/jimmunol.1601301","volume":"198","author":"JF Ashouri","year":"2017","unstructured":"Ashouri, J. F. & Weiss, A. Endogenous Nur77 is a specific indicator of antigen receptor signaling in human T and B cells. J. Immunol. 198, 657\u2013668 (2017).","journal-title":"J. Immunol."},{"key":"75027_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","volume":"567","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature 567, 525\u2013529 (2019).","journal-title":"Nature"},{"key":"75027_CR17","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/eji.202048869","volume":"50","author":"SC Lith","year":"2020","unstructured":"Lith, S. C., van Os, B. W., Seijkens, T. T. P. & de Vries, C. J. M. Nur\u2019turing tumor T cell tolerance and exhaustion: novel function for nuclear receptor Nur77 in immunity. Eur. J. Immunol. 50, 1643\u20131652 (2020).","journal-title":"Eur. J. Immunol."},{"key":"75027_CR18","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1161\/ATVBAHA.120.314607","volume":"40","author":"M Nus","year":"2020","unstructured":"Nus, M. et al. NR4A1 deletion in marginal zone B cells exacerbates atherosclerosis in mice-brief report. Arterioscler. Thromb. Vasc. Biol. 40, 2598\u20132604 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"75027_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.260760","volume":"110","author":"AA Hamers","year":"2012","unstructured":"Hamers, A. A. et al. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ. Res. 110, 428\u2013438 (2012).","journal-title":"Circ. Res."},{"key":"75027_CR20","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.celrep.2018.07.065","volume":"24","author":"DS Koenis","year":"2018","unstructured":"Koenis, D. S. et al. Nuclear receptor Nur77 limits the macrophage inflammatory response through transcriptional reprogramming of mitochondrial metabolism. Cell Rep. 24, 2127\u20132140 e2127 (2018).","journal-title":"Cell Rep."},{"key":"75027_CR21","doi-asserted-by":"publisher","unstructured":"Grassmann, S. et al. Early antigen receptor signaling in natural killer cells alters STAT4-dependent fate decisions via epigenetic remodeling. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.11.07.565992 (2023).","DOI":"10.1101\/2023.11.07.565992"},{"key":"75027_CR22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.aac9407","volume":"350","author":"RN Hanna","year":"2015","unstructured":"Hanna, R. N. et al. Patrolling monocytes control tumor metastasis to the lung. Science 350, 985\u2013990 (2015).","journal-title":"Science"},{"key":"75027_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nchembio.106","volume":"4","author":"Y Zhan","year":"2008","unstructured":"Zhan, Y. et al. Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat. Chem. Biol. 4, 548\u2013556 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"75027_CR24","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/2326-6066.CIR-18-0500","volume":"7","author":"J Cursons","year":"2019","unstructured":"Cursons, J. et al. A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients. Cancer Immunol. Res 7, 1162\u20131174 (2019).","journal-title":"Cancer Immunol. Res"},{"key":"75027_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/ni.2063","volume":"12","author":"RN Hanna","year":"2011","unstructured":"Hanna, R. N. et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 12, 778\u2013785 (2011).","journal-title":"Nat. Immunol."},{"key":"75027_CR26","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.coi.2023.102397","volume":"85","author":"D Schnoegl","year":"2023","unstructured":"Schnoegl, D., Hiesinger, A., Huntington, N. D. & Gotthardt, D. AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity. Curr. Opin. Immunol. 85, 102397 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"75027_CR27","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"75027_CR28","doi-asserted-by":"publisher","unstructured":"Safe, S. et al. Activation of genes by nuclear receptor\/specificity protein (Sp) interactions in cancer. Cancers https:\/\/doi.org\/10.3390\/cancers17020284 (2025).","DOI":"10.3390\/cancers17020284"},{"key":"75027_CR29","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1158\/0008-5472.CAN-10-1992","volume":"70","author":"SO Lee","year":"2010","unstructured":"Lee, S. O. et al. Inactivation of the orphan nuclear receptor TR3\/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res. 70, 6824\u20136836 (2010).","journal-title":"Cancer Res."},{"key":"75027_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.molmed.2019.06.007","volume":"25","author":"J Chen","year":"2019","unstructured":"Chen, J., Gingold, J. A. & Su, X. Immunomodulatory TGF-beta signaling in hepatocellular carcinoma. Trends Mol. Med. 25, 1010\u20131023 (2019).","journal-title":"Trends Mol. Med."},{"key":"75027_CR31","doi-asserted-by":"publisher","unstructured":"Gonzalez-Sanchez, E. et al. The TGF-beta pathway: a pharmacological target in hepatocellular carcinoma? Cancers https:\/\/doi.org\/10.3390\/cancers13133248 (2021).","DOI":"10.3390\/cancers13133248"},{"key":"75027_CR32","doi-asserted-by":"publisher","unstructured":"Mosalmanzadeh, N. & Pence, B. D. Oxidized low-density lipoprotein and its role in immunometabolism. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms252111386 (2024).","DOI":"10.3390\/ijms252111386"},{"key":"75027_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.762828","volume":"9","author":"F Zhou","year":"2021","unstructured":"Zhou, F. & Sun, X. Cholesterol metabolism: a double-edged sword in hepatocellular carcinoma. Front. Cell Dev. Biol. 9, 762828 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"75027_CR34","doi-asserted-by":"publisher","first-page":"E8017","DOI":"10.1073\/pnas.1721049115","volume":"115","author":"M Liebmann","year":"2018","unstructured":"Liebmann, M. et al. Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity. Proc. Natl. Acad. Sci. USA. 115, E8017\u2013E8026 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75027_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi2952","volume":"16","author":"SY Neo","year":"2024","unstructured":"Neo, S. Y. et al. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6\/STAT3 axis. Sci. Transl. Med. 16, eadi2952 (2024).","journal-title":"Sci. Transl. Med."},{"key":"75027_CR36","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1084\/jem.162.6.1745","volume":"162","author":"HG Ljunggren","year":"1985","unstructured":"Ljunggren, H. G. & Karre, K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162, 1745\u20131759 (1985).","journal-title":"J. Exp. Med."},{"key":"75027_CR37","doi-asserted-by":"publisher","unstructured":"Wong, P. Y. et al. Cell cycle inhibitors activate the hypoxia-induced DDX41\/STING pathway to mediate antitumor immune response in liver cancer. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.170532 (2024).","DOI":"10.1172\/jci.insight.170532"},{"key":"75027_CR38","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020).","journal-title":"Nat. Protoc."},{"key":"75027_CR39","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1161\/01.ATV.0000238346.84458.5d","volume":"26","author":"PI Bonta","year":"2006","unstructured":"Bonta, P. I. et al. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol. 26, 2288\u20132294 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"75027_CR40","doi-asserted-by":"crossref","unstructured":"Tzeng, S. F. et al. PLT012, a humanized CD36-blocking antibody, is effective for unleashing antitumor immunity against liver cancer and liver metastasis. Cancer Discov. 15, 1676\u20131696 (2025).","DOI":"10.1158\/2159-8290.CD-24-1409"},{"key":"75027_CR41","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1016\/j.molcel.2021.09.016","volume":"81","author":"H Guo","year":"2021","unstructured":"Guo, H. et al. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer. Mol. Cell 81, 4041\u20134058 e4015 (2021).","journal-title":"Mol. Cell"},{"key":"75027_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114301","volume":"43","author":"J Hao","year":"2024","unstructured":"Hao, J. et al. NR4A1 transcriptionally regulates the differentiation of stem-like CD8(+) T cells in the tumor microenvironment. Cell Rep. 43, 114301 (2024).","journal-title":"Cell Rep."},{"key":"75027_CR43","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1007\/s00262-023-03530-3","volume":"72","author":"K Mohankumar","year":"2023","unstructured":"Mohankumar, K. et al. Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion. Cancer Immunol. Immunother. 72, 3985\u20133999 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"75027_CR44","doi-asserted-by":"publisher","unstructured":"Zeng, Y. et al. Expressions of orphan nuclear receptor TR3\/Nur77 in chronic hepatopathy and its clinical significance. J. Clin. Exp. Oncol. https:\/\/doi.org\/10.4172\/2324-9110.1000188 (2017).","DOI":"10.4172\/2324-9110.1000188"},{"key":"75027_CR45","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1038\/s41388-020-1158-y","volume":"39","author":"YF Guan","year":"2020","unstructured":"Guan, Y. F. et al. Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis. Oncogene 39, 2408\u20132423 (2020).","journal-title":"Oncogene"},{"key":"75027_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/hep.22933","volume":"50","author":"L Chen","year":"2009","unstructured":"Chen, L. et al. Chromodomain helicase\/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 50, 122\u2013129 (2009).","journal-title":"Hepatology"},{"key":"75027_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bbrc.2015.09.091","volume":"466","author":"Y Tan","year":"2015","unstructured":"Tan, Y. & Li, Y. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1. Biochem. Biophys. Res. Commun. 466, 592\u2013598 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75027_CR48","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-17-3102","volume":"78","author":"S Hibino","year":"2018","unstructured":"Hibino, S. et al. Inhibition of Nr4a receptors enhances antitumor immunity by breaking Treg-mediated immune tolerance. Cancer Res. 78, 3027\u20133040 (2018).","journal-title":"Cancer Res."},{"key":"75027_CR49","doi-asserted-by":"publisher","first-page":"113898","DOI":"10.1016\/j.celrep.2024.113898","volume":"43","author":"T Srirat","year":"2024","unstructured":"Srirat, T. et al. NR4a1\/2 deletion promotes accumulation of TCF1(+) stem-like precursors of exhausted CD8(+) T cells in the tumor microenvironment. Cell Rep. 43, 113898 (2024).","journal-title":"Cell Rep."},{"key":"75027_CR50","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/HEP.0000000000000369","volume":"78","author":"M You","year":"2023","unstructured":"You, M. et al. Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC. Hepatology 78, 943\u2013958 (2023).","journal-title":"Hepatology"},{"key":"75027_CR51","doi-asserted-by":"publisher","first-page":"e0150450","DOI":"10.1371\/journal.pone.0150450","volume":"11","author":"RP Duren","year":"2016","unstructured":"Duren, R. P., Boudreaux, S. P. & Conneely, O. M. Genome wide mapping of NR4A binding reveals cooperativity with ETS factors to promote epigenetic activation of distal enhancers in acute myeloid leukemia cells. PLoS ONE 11, e0150450 (2016).","journal-title":"PLoS ONE"},{"key":"75027_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14331-y","volume":"11","author":"MD Carpenter","year":"2020","unstructured":"Carpenter, M. D. et al. Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes. Nat. Commun. 11, 504 (2020).","journal-title":"Nat. Commun."},{"key":"75027_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/imm.13611","volume":"169","author":"W Yu","year":"2023","unstructured":"Yu, W. et al. NR4A1 mediates NK-cell dysfunction in hepatocellular carcinoma via the IFN-gamma\/p-STAT1\/IRF1 pathway. Immunology 169, 69\u201382 (2023).","journal-title":"Immunology"},{"key":"75027_CR54","doi-asserted-by":"publisher","first-page":"1651129","DOI":"10.3389\/fimmu.2025.1651129","volume":"16","author":"V Reverberi","year":"2025","unstructured":"Reverberi, V. et al. TGF-beta-driven NK Cells plasticity in hepatocellular carcinoma. Front. Immunol. 16, 1651129 (2025).","journal-title":"Front. Immunol."},{"key":"75027_CR55","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ni.3800","volume":"18","author":"Y Gao","year":"2017","unstructured":"Gao, Y. et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat. Immunol. 18, 1004\u20131015 (2017).","journal-title":"Nat. Immunol."},{"key":"75027_CR56","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.stem.2024.06.009","volume":"31","author":"JL Thangaraj","year":"2024","unstructured":"Thangaraj, J. L., Coffey, M., Lopez, E. & Kaufman, D. S. Disruption of TGF-beta signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells. Cell Stem Cell 31, 1327\u20131343 e1325 (2024).","journal-title":"Cell Stem Cell"},{"key":"75027_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16754-7","volume":"12","author":"RG Fred","year":"2022","unstructured":"Fred, R. G. et al. Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis. Sci. Rep. 12, 13484 (2022).","journal-title":"Sci. Rep."},{"key":"75027_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2010.11.008","volume":"136","author":"S Yun","year":"2011","unstructured":"Yun, S. et al. TOX regulates the differentiation of human natural killer cells from hematopoietic stem cells in vitro. Immunol. Lett. 136, 29\u201336 (2011).","journal-title":"Immunol. Lett."},{"key":"75027_CR59","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","volume":"19","author":"X Michelet","year":"2018","unstructured":"Michelet, X. et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat. Immunol. 19, 1330\u20131340 (2018).","journal-title":"Nat. Immunol."},{"key":"75027_CR60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fonc.2013.00118","volume":"3","author":"U Koehl","year":"2013","unstructured":"Koehl, U. et al. Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol. Front. Oncol. 3, 118 (2013).","journal-title":"Front. Oncol."},{"key":"75027_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade3341","volume":"15","author":"F Cichocki","year":"2023","unstructured":"Cichocki, F. et al. Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma. Sci. Transl. Med. 15, eade3341 (2023).","journal-title":"Sci. Transl. Med."},{"key":"75027_CR62","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-17-0799","volume":"77","author":"F Cichocki","year":"2017","unstructured":"Cichocki, F. et al. GSK3 inhibition drives maturation of NK cells and enhances their antitumor activity. Cancer Res. 77, 5664\u20135675 (2017).","journal-title":"Cancer Res."},{"key":"75027_CR63","doi-asserted-by":"publisher","unstructured":"Upadhyay, S. et al. Bis-indole derivatives as dual nuclear receptor 4A1 (NR4A1) and NR4A2 ligands. Biomolecules https:\/\/doi.org\/10.3390\/biom14030284 (2024).","DOI":"10.3390\/biom14030284"},{"key":"75027_CR64","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1158\/0008-5472.CAN-09-3160","volume":"70","author":"JJ Liu","year":"2010","unstructured":"Liu, J. J. et al. A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res. 70, 3628\u20133637 (2010).","journal-title":"Cancer Res."},{"key":"75027_CR65","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1016\/j.apsb.2024.07.012","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy. Acta Pharm. Sin. B 14, 5493\u20135504 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"75027_CR66","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.4103\/1673-5374.339492","volume":"17","author":"HZ Yu","year":"2022","unstructured":"Yu, H. Z., Zhu, B. Q., Zhu, L., Li, S. & Wang, L. M. NR4A1 agonist cytosporone B attenuates neuroinflammation in a mouse model of multiple sclerosis. Neural Regen. Res. 17, 2765\u20132770 (2022).","journal-title":"Neural Regen. Res."},{"key":"75027_CR67","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"75027_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43435-w","volume":"13","author":"F Rivest","year":"2023","unstructured":"Rivest, F. et al. Fully automated sequential immunofluorescence (seqIF) for hyperplex spatial proteomics. Sci. Rep. 13, 16994 (2023).","journal-title":"Sci. Rep."},{"key":"75027_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41378-019-0104-z","volume":"5","author":"D Migliozzi","year":"2019","unstructured":"Migliozzi, D. et al. Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections. Microsyst. Nanoeng. 5, 59 (2019).","journal-title":"Microsyst. Nanoeng."},{"key":"75027_CR70","doi-asserted-by":"publisher","unstructured":"Neo, S. Y. et al. Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.187025 (2025).","DOI":"10.1172\/jci.insight.187025"},{"key":"75027_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"75027_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biomaterials.2018.11.016","volume":"192","author":"F Tasnim","year":"2019","unstructured":"Tasnim, F. et al. Generation of mature Kupffer cells from human induced pluripotent stem cells. Biomaterials 192, 377\u2013391 (2019).","journal-title":"Biomaterials"},{"key":"75027_CR73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2018.05.027","volume":"23","author":"M Coll","year":"2018","unstructured":"Coll, M. et al. Generation of hepatic stellate cells from human pluripotent stem cells enables in vitro modeling of liver fibrosis. Cell Stem Cell 23, 101\u2013113 e107 (2018).","journal-title":"Cell Stem Cell"},{"key":"75027_CR74","doi-asserted-by":"publisher","first-page":"e90954","DOI":"10.1172\/jci.insight.90954","volume":"1","author":"RE Feaver","year":"2016","unstructured":"Feaver, R. E. et al. Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight 1, e90954 (2016).","journal-title":"JCI Insight"},{"key":"75027_CR75","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424\u20131435 (2017).","journal-title":"Nat. Med."},{"key":"75027_CR76","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"},{"key":"75027_CR77","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"75027_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).","journal-title":"Sci. Rep."},{"key":"75027_CR79","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"75027_CR80","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ramirez","year":"2016","unstructured":"Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"75027_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"75027_CR82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fgene.2014.00075","volume":"5","author":"TS Carroll","year":"2014","unstructured":"Carroll, T. S., Liang, Z., Salama, R., Stark, R. & de Santiago, I. Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data. Front. Genet. 5, 75 (2014).","journal-title":"Front. Genet."},{"key":"75027_CR83","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"75027_CR84","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495\u2013501 (2010).","journal-title":"Nat. Biotechnol."},{"key":"75027_CR85","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/bioinformatics\/btr189","volume":"27","author":"P Machanick","year":"2011","unstructured":"Machanick, P. & Bailey, T. L. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27, 1696\u20131697 (2011).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75027-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75027-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75027-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:03:32Z","timestamp":1786406612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75027-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75027"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75027-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Johan Hartman has obtained speaker\u2019s honoraria or advisory board remunerations from Roche, Novartis, AstraZeneca, Pfizer, Eli Lilly, MSD, Sakura, and Gilead and has received institutional research support from Cepheid, Novartis, Roche, MSD, and AstraZeneca. Johan Hartman is a co-founder and shareholder of Stratipath AB. All other authors declare no competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8132"}}